FILANA THERAPEUTICS, INC.
Company Stats
- Market Cap
- $42.8M
- as of Sep 30, 2026
- Shares Outstanding
- 48.3M
- Free Float
- 87.9%
Income Statement
- Operating Income
- -$95.4M
- Net Income
- -$91.0M
- EBITDA
- -$94.5M
Cash Flow
- Free Cash Flow
- -$32.8M
- FCF Yield
- -76.7%
- Owner FCF Yield
- -122.5%
Balance Sheet
- Cash & Equivalents
- $95.5M
Returns & Capital
- SBC, 3Y Avg
- $13.5M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | — | -$32.8M | — |
| FY2024 | — | -$117.0M | — |
| FY2023 | — | -$82.4M | — |
| FY2022 | — | -$80.2M | — |
| FY2021 | — | -$52.4M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 7, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Microcap Insider Buying: Week Ending October 2, 2026